{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:54:48Z","timestamp":1761490488363,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/12\/2\/20422"],"award-info":[{"award-number":["SP\/12\/2\/20422"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2542-6","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T06:39:48Z","timestamp":1520231988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"name":"the RESTART collaborators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon D.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Innes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Drever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Dinsmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William N.","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A. G.","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathie L. M.","family":"Sudlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Werring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"issue":"6","key":"2542_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","volume":"85","author":"MT Poon","year":"2014","unstructured":"Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(6):660\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9678","key":"2542_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Antithrombotic Trialists Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849\u201360.","journal-title":"Lancet"},{"key":"2542_CR3","first-page":"CD001925","volume":"4","author":"M Aguilar","year":"2005","unstructured":"Aguilar M, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2005;4:CD001925.","journal-title":"Cochrane Database Syst Rev"},{"key":"2542_CR4","first-page":"CD012144","volume":"5","author":"LA Perry","year":"2017","unstructured":"Perry LA, Berge E, Bowditch J, Forfang E, Ronning OM, Hankey GJ, Villanueva E, Al-Shahi Salman R. Antithrombotic treatment after stroke due to intracerebral haemorrhage. Cochrane Database Syst Rev. 2017;5:CD012144.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2542_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","volume":"75","author":"A Biffi","year":"2010","unstructured":"Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, Smith EE, Greenberg MS, Rosand J, Viswanathan A. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693\u20138.","journal-title":"Neurology"},{"issue":"2","key":"2542_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1160\/TH11-06-0439","volume":"107","author":"BH Chong","year":"2012","unstructured":"Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, Lui WM, Leung GK, Lau CP, Tse HF, et al. Use of aspirin in Chinese after recovery from primary intracranial haemorrhage. Thromb Haemost. 2012;107(2):241\u20137.","journal-title":"Thromb Haemost"},{"issue":"11","key":"2542_CR7","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/STROKEAHA.110.589143","volume":"41","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke. 2010;41(11):2606\u201311.","journal-title":"Stroke"},{"key":"2542_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.wneu.2017.06.015","volume":"106","author":"KC Teo","year":"2017","unstructured":"Teo KC, Lau GK, Mak RH, Leung HY, Chang RS, Tse MY, Lee R, Leung GK, Siu DC, Cheung RT, et al. Antiplatelet resumption after antiplatelet-related intracerebral hemorrhage: a retrospective hospital-based study. World Neurosurg. 2017;106:85\u201391.","journal-title":"World Neurosurg"},{"issue":"1","key":"2542_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","volume":"152","author":"JJ Sung","year":"2010","unstructured":"Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152(1):1\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2542_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-017-1909-4","volume":"18","author":"AE Maxwell","year":"2017","unstructured":"Maxwell AE, MacLeod MJ, Joyson A, Johnson S, Ramadan H, Bellfield R, Byrne A, McGhee C, Rudd A, Price F, et al. Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. Trials. 2017;18(1):162.","journal-title":"Trials"},{"issue":"1","key":"2542_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13063-016-1692-7","volume":"18","author":"AE Maxwell","year":"2017","unstructured":"Maxwell AE, Dennis M, Rudd A, Weir CJ, Parker RA, Al-Shahi Salman R. Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART). Trials. 2017;18(1):22.","journal-title":"Trials"},{"issue":"1","key":"2542_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13063-017-1840-8","volume":"18","author":"RA Parker","year":"2017","unstructured":"Parker RA, Weir CJ, Maxwell AE, Al-Shahi Salman R. Promoting Recruitment using Information Management Efficiently (PRIME): statistical analysis plan for a stepped wedge cluster randomised trial within the REstart or STop Antithrombotics Randomised Trial (RESTART). Trials. 2017;18(1):94.","journal-title":"Trials"},{"issue":"5","key":"2542_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/STROKEAHA.109.571562","volume":"41","author":"A Bruno","year":"2010","unstructured":"Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, Baute V, Switzer JA, Waller JL, Nichols FT. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010;41(5):1048\u201350.","journal-title":"Stroke"},{"issue":"3","key":"2542_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/STROKEAHA.111.639708","volume":"43","author":"M Dennis","year":"2012","unstructured":"Dennis M, Mead G, Doubal F, Graham C. Determining the modified Rankin score after stroke by postal and telephone questionnaires. Stroke. 2012;43(3):851\u20133.","journal-title":"Stroke"},{"issue":"8","key":"2542_CR15","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","volume":"42","author":"A Bruno","year":"2011","unstructured":"Bruno A, Akinwuntan AE, Lin C, Close B, Davis K, Baute V, Aryal T, Brooks D, Hess DC, Switzer JA, et al. Simplified modified Rankin Scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke. 2011;42(8):2276\u20139.","journal-title":"Stroke"},{"issue":"6","key":"2542_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/1747493016641960","volume":"11","author":"N Sprigg","year":"2016","unstructured":"Sprigg N, Robson K, Bath P, Dineen R, Roberts I, Robinson T, Roffe C, Werring D, Al-Shahi Salman R, Pocock S, et al. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial. Int J Stroke. 2016;11(6):683\u201394.","journal-title":"Int J Stroke"},{"issue":"8","key":"2542_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","volume":"119","author":"KR McQuaid","year":"2006","unstructured":"McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006;119(8):624\u201338.","journal-title":"Am J Med"},{"issue":"1","key":"2542_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/STROKEAHA.108.526996","volume":"40","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, Wardlaw JM, Al-Shahi Salman R. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke. 2009;40(1):94\u20139.","journal-title":"Stroke"},{"issue":"21","key":"2542_CR19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"SM Gregoire","year":"2009","unstructured":"Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, Werring DJ. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759\u201366.","journal-title":"Neurology"},{"issue":"8","key":"2542_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O\u2019Brien JT, Barkhof F, Benavente OR, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"3","key":"2542_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"2542_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"2542_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12916-015-0532-z","volume":"13","author":"C Tudur Smith","year":"2015","unstructured":"Tudur Smith C, Hopkins C, Sydes MR, Woolfall K, Clarke M, Murray G, Williamson P. How should individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med. 2015;13:298.","journal-title":"BMC Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2542-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T19:07:47Z","timestamp":1551726467000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2542-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2542-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"23 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Scotland A Research Ethics Committee approved RESTART before recruitment began (reference 12\/SS\/0138). Collaborators who have received GCP and RESTART-specific training and are included in a delegation log obtain written informed consent from participants or their legal representative or nearest relative.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"162"}}